Le rapport
Actualités vérifiées sur le financement, les sièges sociaux et les dirigeants des entreprises les plus innovantes au monde
10,537 rapports et plus encore
Delos Data Raises More Than $100M for Nonstop AI Infrastructure
Delos Data raised more than $100 million to launch its Nonstop AI architecture and scale engineering, product development, and sales.
Crusoe Energy Raises $500 Million in Growth Funding - October 2024
Crusoe Energy announced $500 Million in Growth Funding funding at a $3 Billion valuation. Crusoe Energy raised $500 million led by Peter Thiel's Founders Fund to build AI-optimized data centers powered by natural gas, with major contracts f...
Databricks reaches $43B valuation with $500M Series J funding
Databricks raises $500M in Series J funding as enterprises accelerate data and AI initiatives, reaching a $43B valuation.
OpenAI raises $6.6B in Series C funding, reaches $157B valuation
OpenAI closes one of the largest funding rounds in history, raising $6.6 billion to accelerate AI research and expand global operations.
AeroVault raises $600M Series D in September 2025 funding round
AeroVault secures $600M in Series D funding in September 2025, reaching $8.5B valuation to advance its space-based data storage and computing infrastructure platform.
RoboLogistics raises $320M Series C in September 2025 funding round
RoboLogistics secures $320M in Series C funding in September 2025, reaching $3.8B valuation to advance its autonomous warehouse robotics and fulfillment automation.
NeuroPharma raises $190M Series B in September 2025 funding round
NeuroPharma secures $190M in Series B funding in September 2025, reaching $1.6B valuation to advance its neurological drug discovery using ai and machine learning.
FlexiPay raises $290M Series C in September 2025 funding round
FlexiPay secures $290M in Series C funding in September 2025, reaching $4.1B valuation to advance its flexible payment platform for b2b transactions and cash flow management.
BioSynth Labs raises $380M Series B in September 2025 funding round
BioSynth Labs secures $380M in Series B funding in September 2025, reaching $3.2B valuation to advance its synthetic biology platform for sustainable chemical manufacturing.
Affichage de 9 rapports • Page 1 • Catégorie : all
Restez en avance sur le marché
Recevez des insights hebdomadaires dans votre boîte de réception. Pas de spam, juste de l'intelligence.